Skip to content
ClinCalc Pro
Menu
Strong opioid analgesic

Morphine Sulphate (Burns Analgesia)

Brand names: Zomorph, MST Continus, Oramorph

Morphine sulphate is a strong opioid agonist used as a mainstay of acute and procedural analgesia for burn injuries, given parenterally for severe pain and during dressing changes and debridement.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It is an agonist at mu-opioid receptors in the central nervous system, inhibiting ascending nociceptive transmission and altering the perception of and response to pain.

Prescribing in practice

  • Titrate to effect with close observation for respiratory depression and sedation, monitoring oxygen saturation and conscious level, and have naloxone available.
  • Burns produce dynamic and often escalating pain with hyperalgesia and opioid tolerance, so requirements may be high and are best managed within a multimodal regimen and on a background-plus-procedural model.
  • Active metabolites accumulate in renal impairment, so reduce frequency and monitor more closely when renal function is reduced, which is common in major burns.

Monitoring

Monitor pain scores, respiratory rate, sedation and oxygen saturation during titration, with continuous observation for procedural dosing.

Counselling the patient

  • This strong painkiller will be adjusted to your pain and monitored closely.
  • Tell staff if you feel very drowsy, sick or short of breath.
  • Constipation is common and laxatives are usually given alongside.

Evidence & guidelines

Opioids including morphine are recommended as core burns analgesia by burn-care guidance, used within a multimodal, procedural-and-background framework.

Reference: British Burns Association Analgesia Guidelines; ANZBA Burns Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.